Dynamics of T Cells Subsets and Lymphoproliferative Responses During Structured Treatment Interruption Cycles and After Definitive Interruption of HAART in Early Chronic HIV Type-1-Infected Patients
- 1 July 2006
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 22 (7) , 657-666
- https://doi.org/10.1089/aid.2006.22.657
Abstract
Little is known about the consequences of short cycles of structured treatment interruption or definitive interruption of HAART for both T cell subset dynamics and T lymphoproliferative responses (LPR). Immunological follow-up was performed in 45 early chronical HIV-1-infected patients during short STI cycles during the first 12 weeks after the definitive interruption of HAART (DTI) and, thereafter, until VL reached a plateau. During STI cycles, CD8+, CD8+, CD28+, activation markers and naive CD4+ T cells increased significantly (p < 0.0001), while both naive CD8+ and memory CD4+ T cells decreased. During DTI, CD8+ CD28+ T cells fell and CD4+ naive T cells stabilized and the rest of the T cell subsets presented changes similar to those during STI cycles. Despite a transient increase in LPR to recall antigens and HIV proteins during STI cycles, LPR to polyclonal stimuli and pathogens decreased over the study. Differences in T cell subset dynamics and LPR observed throughout the study suggest that multiple exposures to low levels of antigen could improve the immune system, mainly by driving T cell maturation. Conversely, higher and longer viral replication after cessation of HAART overwhelms the immune system. These data may help to guide future immune-based therapies.Keywords
This publication has 35 references indexed in Scilit:
- Immunopathogenesis and immunotherapy in AIDS virus infectionsNature Medicine, 2003
- The Challenge of Viral Reservoirs in HIV-1 InfectionAnnual Review of Medicine, 2002
- Reconstitution of CD4+ T lymphocytes in HIV-infected individuals following antiretroviral therapyCurrent Opinion in Immunology, 2001
- Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort studyPublished by Elsevier ,2001
- Structured treatment interruptions to control HIV-1 and limit drug exposureTrends in Immunology, 2001
- Transient Mobilization of Human Immunodeficiency Virus (HIV)-Specific CD4 T-Helper Cells Fails To Control Virus Rebounds during Intermittent Antiretroviral Therapy in Chronic HIV Type 1 InfectionJournal of Virology, 2001
- Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapyAIDS, 1999
- HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppressionNature Medicine, 1999
- Lack of T-cell proliferative response to HIV-1 antigens after 1 year of highly active antiretroviral treatment in early HIV-1 diseaseThe Lancet, 1998
- Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNAScience, 1998